Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Arch Biopartners Inc. announced that three additional clinical sites in Turkey have joined the Phase II trial for LSALT peptide targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI).
read more
Adare and NLS announced a collaboration to develop mazindol CR product candidates for the treatment of narcolepsy and ADHD.
read more
PerkinElmer announced a research team at NCATS is working with PerkinElmer’s AlphaLISA immunoassay to support the global search for effective COVID-19 therapeutics.
read more
Tuesday, October 11, 2022
The Outsourcing Facilities Association (OFA) announced that it has reached a settlement agreement with the FDA that spurs the FDA to promptly review long-pending nominations for active pharmaceutical ingredients for use by FDA-registered outsourcing ...
read more
Allied Patients has launched to develop affordable generic medications and do right by patients.
read more
Wednesday, August 08, 2018
Scientist.com and Orphagen Pharmaceuticals have partnered to offer researchers online access to nuclear receptor profiling and screening services.
read more
Integral Molecular has successfully reached the first milestone in its collaboration with Daiichi Sankyo to discover new immuno-oncology (I-O) therapeutic targets.
read more
Iovance Biotherapeutics has expanded its relationship with WuXi AppTec's Advanced Therapies Business Unit (WuXi ATU).
read more
Aesica, the global contract development and manufacturing organisation (CDMO), has appointed Sven Thomas and David Ross as business development managers. Their appointment is the next phase in the company’s international drive to increase sales from ...
read more
Medical device manufacturers hoping to enter the US market face increasing commercial competition and challenges to gain the funding necessary to support emerging brands. Because development and commercialization can consume a lot of resources, many...
read more
Lonza announced the launch of its Media Development Lab at its Singapore site. The offering aims to support bioprocessing customers in optimizing their media formulations and facilitating a smooth transition to GMP manufacturing, helping reduce scale...
read more
Wednesday, November 27, 2019
JanOne has announced a licensing agreement for TV1001SR, a treatment for Peripheral Artery Disease.
read more
Contract Pharmacal plans to expand into a new space on Long Island, New York.
read more
Thursday, October 29, 2020
SFJ announced its partner Apellis has formed a strategic collaboration to accelerate the advancement of systemic pegcetacoplan.
read more
ViraCyte has been awarded $3.75M from National Institutes of Health and the FDA to advance its T cell immunotherapies.
read more